Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03703895 · ClinicalTrials.gov registry record · Phase 4
A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis
A Phase 4 study, sponsored by The Center for Clinical and Cosmetic Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03703895 is a Phase 4 study that has completed, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 20 participants.
The verdict
NCT03703895, a Phase 4 study, has completed, sponsored by The Center for Clinical and Cosmetic Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a double-blind, pilot study with 20 subjects to determine the tolerability and efficacy of topical AFX 5931 in the treatment of mild to moderate hand dermatitis. Subjects are screened up to 30 days before the baseline visit. Subjects who meet the eligibility criteria may qualify for the study. Subjects will be randomized in a 3:1 ratio to receive either the active or vehicle medication. 15 subjects will receive the active, therapeutic product and 5 subjects will receive the inactive, vehicle product.
Interventions
- DRUG Topical Placebo
- DRUG Topical AFX5931
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-09-18 |
| Est. Completion | 2019-04-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03703895
The ClinicalTrials.gov registry entry for NCT03703895 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Clinical and Cosmetic Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical Placebo is the first listed.
NCT03703895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03703895 about?
NCT03703895 is a clinical study titled "A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis". This is a double-blind, pilot study with 20 subjects to determine the tolerability and efficacy of topical AFX 5931 in the treatment of mild to moderate hand dermatitis. Subjects are screened up to 30 days before the baseline visit. Subjects who meet the eligibility criteria may qualify for the stud...
What is the current status of trial NCT03703895?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2018-09-18. Estimated completion is 2019-04-04.
What interventions are being tested in trial NCT03703895?
The interventions under investigation include: Topical Placebo (DRUG), Topical AFX5931 (DRUG).
Who is sponsoring clinical trial NCT03703895?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.